October 25, 2023
TCT DurAVR® THV FIH Data Presentation
See the latest DurAVR® THV First-in-Human (FIH) Study data presented by Dr Christopher Meduri at TCT 2023, showing sustained mean hemodynamic performance from all 20 patients at 6 months post-procedure.